ABOUT THE AUTHORS


The ADT Book is the product of the ADT Working Group which is made up of clinicians and researchers from medical and academic institutions across Canada. Our goal is to investigate and facilitate ways to help prostate cancer patients manage the side effects of androgen deprivation therapy (ADT). These medications (such as Lupron®, Zoladex®) help control prostate cancer growth by shutting down testosterone production from the testes. However, the depletion of testosterone has a number of side effects that impact the lives of both patients and their loved ones. To deal with these problems, we produced Androgen Deprivation Therapy: An essential guide for men with prostate cancer and their loved ones. The book contains extensive information on ADT, introduces the side effects patients may experience while on ADT, and provides strategies to help them and their loved ones deal with those side effects in order to maintain good health and quality of life.

A French version of the ADT Book is now available at puq.ca.

 

LEAD AUTHORS

Richard Wassersug, PhD 

A research scientist, who received his PhD in evolutionary biology from the University of Chicago. He then spent most of his career studying the biology of amphibians and teaching anatomy in the medical school at Dalhousie University in Halifax, Nova Scotia. At the age of 52 Richard was diagnosed with prostate cancer and has since received multiple treatments for the disease. After beginning androgen deprivation therapy, he redirected his research to study the psychology of androgen deprivation in various populations. Richard is now an Honorary Professor in the Department of Cellular and Physiological Sciences at the University of British Columbia. He is also an Adjunct Professor in the Australia Research Centre in Sex, Health and Society in Melbourne, Australia.

 

Lauren Walker, PhD

A clinical psychologist and a Research Assistant Professor in the Department of Oncology at the University of Calgary and the Tom Baker Cancer Centre. She completed her doctorate research evaluating an educational initiative for preparing prostate cancer patients (and their partners) to manage the side effects of ADT. She works clinically with couples helping them adapt to the sexual implications of cancer treatments. She is an active researcher, who has contributed several key articles to the scientific literature on the psychosocial adaptation to ADT. Recently she received the Rising Star in Prostate Cancer Research Award from Prostate Cancer Canada/Movember.

 

John Robinson, PhD

A clinical psychologist and a member of the Genital Urinary Program at the Tom Baker Cancer Centre in Calgary, Alberta since 1986. He concurrently provides clinical service and develops new ways to ease the psychological burden of cancer on not just patients but also their loved ones. He has appointments in both Oncology and Clinical Psychology at the University of Calgary where he teaches and carries on an active research program.


The ADT book also has additional contributions from:

Kristen L. Currie, MA, CCRP, Kirsten Kukula, BSc, Linette Lawlor-Savage, MSc, Andrew Matthew, PhD, C Psych, Deborah McLeod, RN, PhD, Daniel Santa Mina, CEP PhD, and Cheri Van Patten, RD, MSc